Search for: "Free v. Abbott Laboratories" Results 21 - 40 of 68
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Sep 2013, 5:30 am by Barry Sookman
Abbott Laboratories, Limited, 2013 ONCA 555 http://t.co/hLfuHyi6kT -> Beastie Boys Can't Escape 'Paul's Boutique' Sampling Laws [read post]
28 Oct 2011, 7:00 am by Bexis
Abbott Laboratories, Inc., 259 F.3d 1226, 1235 (10th Cir. 2001) ([the prescribing nurse’s] “failure to read the label - a basic task which she was trained to perform - was an efficient intervening cause of [plaintiff’s] injury”) (applying Kansas law). [read post]
26 Jan 2011, 9:52 am by Rebecca Tushnet
Lacey, Division Counsel, Abbott Laboratories I came in near the end, but Lacey emphasized that a marketer needs to know the difference between labeling (FDA authority) and other material (FTC)—if you detail to pediatricians about foods with nutritional benefits, for example, FDA largely prohibits nutrient claims for kids under 2. [read post]
1 Oct 2010, 5:25 am by Maxwell Kennerly
Abbott Laboratories forecast NeoProfen could be sold for $450-500 per treatment course. [read post]
30 Aug 2010, 6:20 pm
Abbott Laboratories, 124 F.3d 1419 (Fed. [read post]
14 May 2010, 11:27 am
Cir. 2005); Abbott Labs. v. [read post]
7 Apr 2010, 3:44 pm by admin
Click Here EPA Settles with Drug and Laboratory Disposal on Hazardous Waste Violations. [read post]
7 Apr 2010, 4:30 am
– Myriad stock prices: Association of Molecular Pathology v USPTO (Innovationpartners) US: Federal judge in Myriad patent case says invalidation of gene patents does not violate TRIPS: Association of Molecular Pathology v USPTO (KEI) US: ACLU gene patent decision from an investor’s perspective: A black eye for the US patent system: Association of Molecular Pathology v USPTO (Holman's Biotech IP Blog) US: Association of Molecular Pathology v USPTO:… [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) Omnicef (Cefdinir) – US: CAFC on whether a product-by-process claim is infringed by an identical product made by different process: Abbott Labs v Sandoz (IP Frontline) Pertussis vaccines – UK: EWHC dismisses Medeva appeal against pertussis vaccines SPCs refusal (The SPC Blog) Plavix (Clopidogrel) – Canada: Adding some obvious flexibility: Apotex Inc v Sanofi-Synthelabo Canada Inc… [read post]
11 Dec 2009, 5:00 am
Abbott Laboratories, 607 P.2d 924 (Cal. 1980). [read post]